Objective: The purpose of this study was to retrospectively evaluate the diagnostic accuracy and complications of CTguided core needle biopsy (CT-guided CNB) of pleural lesion and the possible effects of influencing factors. Materials and Methods: From September 2007 to June 2013, 88 consecutive patients (60 men and 28 women; mean [± standard deviation] age, 51.1 ± 14.4 years; range, 19-78 years) underwent CT-guided CNB, which was performed by two experienced chest radiologists in our medical center. Out of 88 cases, 56 (63%) were diagnosed as malignant, 28 (31%) as benign and 4 (5%) as indeterminate for CNB of pleural lesions. The final diagnosis was confirmed by either histopathological diagnosis or clinical follow-up. The diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and complication rates were statistically evaluated. Influencing factors (patient age, sex, lesion size, pleural-puncture angle, patient position, pleural effusion, and number of pleural punctures) were assessed for their effect on accuracy of CT-guided CNB using univariate and subsequent multivariate analysis. Results: Diagnostic accuracy, sensitivity, specificity, PPV, and NPV were 89.2%, 86.1%, 100%, 100%, and 67.8%, respectively. The influencing factors had no significant effect in altering diagnostic accuracy. As far as complications were concerned, occurrence of pneumothorax was observed in 14 (16%) out of 88 patients. Multivariate analysis revealed lesion size/pleural thickening as a significant risk factor (odds ratio [OR]: 8.744, p = 0.005) for occurrence of pneumothorax. Moreover, presence of pleural effusion was noted as a significant protective factor (OR: 0.171, p = 0.037) for pneumothorax. Conclusion: CT-guided CNB of pleural lesion is a safe procedure with high diagnostic yield and low risk of significant complications.
INTRODUCTION
Both neoplastic (primary and metastatic) and nonneoplastic pleural disease can exhibit similar clinical, radiographic and gross features including pleuritic pain, pleural-based masses or pleural thickening and pleural effusion. Accurate differential diagnosis between malignant and benign pleural disease is crucial because of the associated differences in the management and prognosis of respective lesions (1) .
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The role of ultrasonography (US) in the chest region has traditionally been limited when compared with computed tomography (CT) (2) . Consequently, US has been employed for evaluation of pleural effusion, pneumothorax and pulmonary fibrosis (3, 4) . Apart from serving as a diagnostic procedure, it also serves as guidance for thoracentesis and chest tube placement (5) . Real-time multiplanar monitoring of the procedure along patient's bedside without the use of ionizing radiation is one of the major advantages of US. Thoracoscopy, either medical (pleuroscopy) or surgical (video-assisted thoracoscopic surgery, VATS) has a diagnostic yield of 91-95% for pleural malignancy, and up to 100% for pleural tuberculosis (TB) (6, 7) . However, access to thoracoscopy is limited in many healthcare systems due to requirement of significant resources and expertise, including appropriate anesthetic support (8) . CT, due to technical advancement, has rapidly become the guidance modality of choice for performing biopsy of pleural lesion; moreover, CT-guided biopsy offers a readily accessible, minimally invasive, rapid and low-cost alternative approach when compared to thoracoscopy to obtain sample tissues (8) .
Lung biopsy performed under CT guidance is an established and well-described diagnostic technique. There exist several published guidelines regarding the best practice of this procedure. However, in comparison to CTguided lung biopsy, fewer reports are available about the risk factors of complications of CT-guided pleural biopsies. Therefore, the purpose of this study was to evaluate diagnostic accuracy and complications of CT-guided core needle biopsy (CT-guided CNB) of pleural lesions and to determine the effect of possible influencing factors.
MATERIALS AND METHODS
This retrospective study was approved by the Institutional Review Board and by the ethics commission. The acquisition of informed consent from patients was waived, as the study retrospectively utilized data available in electronic medical records.
Study Population
From September 2007 to June 2013, a cohort of 88 consecutive CT-guided CNB for pleural lesions in 88 patients (60 men and 28 women; mean [± standard deviation] age, 51.1 ± 14.4 years; range, 19-78 years) was subjected to analyze factors influencing accuracy and complications in patients who underwent CT-guided CNB of pleural lesions at our medical center. The mean interval from diagnostic CT scan to the biopsy procedure was 14.5 days (range: 0-28 days).
Inclusion and Exclusion Criteria for Biopsy
Inclusion criteria for the trial were: 1) pleural or peripherally located lung lesions with at least a small degree of contact with the pleura; 2) pleural lesions/pleural thickening > 5 mm in maximum diameter; 3) unilateral pleural effusion with clinical suspicion of malignant pleural disease; 4) at least one negative pleural fluid cytological examination for malignant cells; 5) patient had normal platelet counts, activated partial prothrombin time within 3 days of undergoing needle biopsy; and 6) patient could tolerate a recumbent position. Our exclusion criteria were: 1) pleural lesions/pleural thickening < 5 mm in maximum diameter; 2) centrally located small pleural nodule (< 5 mm) with pleural effusion; 3) transudative pleural effusion (pleural fluid protein < 35 g/dL) associated with heart failure or hypoalbuminemia, such that the clinical prior probability of a hydrostatic effusion was high; 4) pleural fluid cytological examination showing definite malignant cells; 5) any bleeding diathesis sufficient to make pleural biopsy unusually hazardous; and 6) patients who could not follow verbal or visual instruction, and patients or family members who could not accept procedure-related risks.
Biopsy Procedure
The patients fasted for at least 4 hours prior to the procedure. The procedure was performed with the patient in a prone, supine or lateral decubitus position depending upon the location of the lesion. Electrocardiography, percutaneous oxygen saturation and blood pressure were monitored constantly during the procedure. The procedure was performed under conscious sedation. Most of the patients had contrast-enhanced chest CT scans available for review before the biopsy procedures. Prior to the procedure, diagnostic CT and new localization CT scan images were carefully reviewed to determine the best target and the most appropriate route for successful and safe tissue sampling. A skin marker (a radiopaque thin stick or grid) was placed on the body surface corresponding to the target lesion. All the patients underwent selected 3 mm sections through the area of interest using a single-section spiral CT machine (Xvision, Toshiba, Tochigi, Japan). Images through the region of interest were viewed under a combination of lung and soft-tissue window settings. To confirm the optimal puncture route, the position of the patient or arm was adjusted and additional CT imaging was performed, if necessary.
At the site of puncture, approximately 3 mL of 1% lidocaine was injected subcutaneously as local anesthesia. Two experienced operators performed CT-guided biopsy procedures with a 19-G needle (TruGuide, Bard, AZ, USA) and image guidance. After needle insertion, a CT scan was done to confirm the position of the needle after which the stylet was removed and core biopsy was performed with the matching 20-G cutting needle (Magnum Needles, Bard, AZ, USA) and a biopsy gun (Magnum, Bard, AZ, USA) (Figs. 1, 2). The operator visually checked adequacy of the specimen. If the sample amount was judged as insufficient, a new inner needle was inserted through the remaining outer needle, the tip position was once more adjusted under CT scan and the tissue sample was again obtained. The operator repeated this procedure until sufficient amount of tissue for histopathological diagnosis was obtained. Specimens were obtained from individual patients; and each specimen was placed in an individual 10% formalinfilled container. The baseline characteristics of the lesions and procedures are summarized in Table 1 . Immediately after biopsy, unenhanced CT scan (slice thickness, 10 mm) of the whole thorax was performed to check for immediate pneumothorax. If immediate development of small, asymptomatic pneumothorax was observed, the patient was treated conservatively by administration of supplemental oxygen. Follow-up chest radiography was performed to evaluate the stability of pneumothorax. Any immediate occurrence of a moderate pneumothorax, defined as a collapse of the lung surface ≥ 2 cm from the site of the needle puncture, was aspirated by reinsertion of the coaxial needle guide. Patients were given chest tube insertion if the pneumothorax worsened or was accompanied by symptoms such as respiratory distress, shortness of breath, pain and decreased oxygen saturation. Patients without Note.-Lesion size was measured along maximum long-axis diameter. Number of pleural punctures was number of times puncture was made through pleura. Histopathology of specimen revealed pleural fibrosis. kjronline.org 209
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Establishing Final Outcomes of Biopsy Results
One radiologist reviewed the pathology reports of biopsy specimens, follow-up images and surgical specimens of patients, who underwent surgical resection. Lesion changes over time were investigated on follow-up images and the mean follow-up period was 13 months (range: 7-20 months) in our study. Final diagnosis was confirmed in four ways. First, if the patient had underwent surgical resection (n = 11) for the pleural lesion, final diagnosis was considered to be matching with the pathologic reports of the surgical specimen. Second, if a malignant or specific benign pathologic abnormality (e.g., mesothelioma and TB) (n = 64) was reported because of biopsy, then the biopsy result was accepted as the final diagnosis. Third, if a nonspecific benign pathologic abnormality (e.g., negative for malignancy or chronic inflammation) was reported as a result of biopsy and there was at least a 20% decrease in lesion diameter or the lesion was stable (n = 9) during the follow-up of more than 1 year on chest radiograph or CT scan, then the final diagnosis was recorded as benign. Finally, if a nonspecific benign pathologic abnormality was reported as a result of biopsy, but the lesion did not exhibit sufficient interval decrease in size or could not be tracked by follow-up images, then its final diagnosis was defined as undetermined (n = 4).
Statistical Analysis
Using the final histological diagnoses and the clinical and radiological course of the diseases as reference, positive biopsy results were categorized as true-positive or falsepositive, if the final diagnosis was malignant or benign disease, respectively. Similarly, negative biopsy results were categorized as true-negative or false-negative, in case the final diagnosis was benign or malignant disease, respectively. Subsequently, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the CNB diagnoses and the overall diagnostic accuracy were calculated. Undetermined nodules were not included in the calculation of diagnostic accuracy, sensitivity and specificity (9 
RESULTS

Diagnostic Performance
The pathological diagnoses, which were determined by a CT-guided CNB of pleural lesions and various methods for final diagnoses, are detailed in Table 2 . CNB diagnoses included 28 benign, 56 malignant and four undetermined 
Procedure-Related Complications
In terms of procedure-related complications, pneumothorax was detected in 14 patients (16.0%) and chest pain in 2 patients (2%). No incidence of hemoptysis or deaths was noted in the study group. However, hemothorax was detected in one (1%) patient after biopsy; which later was hemodynamically stable and did not required transfusion. There were significant differences between the pneumothorax group and the non-pneumothorax group in terms of lesion size/pleural thickness (cm) (p = 0.029), pleural effusion (p = 0.027) and the number of pleural punctures (p = 0.011) ( Table 5 ). Multivariate analysis revealed lesion/pleural thickening size as a significant independent risk factor (odds ratio [OR], 8.744; 95% confidence interval [CI], 1.957-39.073; p = 0.005), and the presence of pleural effusion as a significant independent protective factor (OR, 0.171; 95% CI, 0.033- Note.-Undetermined CNB diagnoses and final diagnoses were excluded from calculation. CNB = core needle biopsy CT-Guided Core Needle Biopsy of Pleural Lesions 0.901; p = 0.037) ( Table 6 ). Factors such as patient's age, sex, pleural-puncture angle, patient position, and number of pleural punctures were not associated with an increased risk of pneumothorax.
DISCUSSION
Computed tomography scan provides excellent contrast and spatial resolution and enables accurate needle placement making it the most widely used guidance technique for percutaneous transthoracic interventional procedures. The results from the present study propose CT as a safe and effective guidance modality for the biopsy of pleural lesions. However, the use of ionizing radiation, lack of real-time capability and visualization of only transverse sections are major limitations of CT-guided pleural biopsy.
The overall sensitivity of 86.1% for the 88 pleural lesions in our study is essentially equal to the sensitivities reported in previous studies (10) (11) (12) and the rate of nondiagnostic pleural biopsies (5%) also comparable with prior research (13) . In cases of CNB diagnoses, when a malignant diagnosis is identified by needle biopsy, the clinical decision-making process is generally straightforward due to the extremely low false-positive rates (14) . However, when a benign diagnosis is obtained, there is a clinical uncertainty over how to proceed, because a number of these lesions may prove to be malignant (false negatives). Accordingly, it is recommended that patients with benign CNB diagnoses undergo repeat imaging within one or more years in order to document the stability or resolution of the pleural lesions. If the lesion grows in size, a repeat biopsy or VATS may be required to obtain a definitive diagnosis (15) .
There are several factors, which possibly contributes to the diagnostic advantage of CT-guided pleural biopsy, as seen in this study. Primarily, the ability of imaging to ensure that the biopsy specimen is taken from an area of abnormal pleural tissue is certainly the obvious one. Results of observational series have suggested a substantial improvement in quality of samples in situations where CT-guided biopsy is employed. Second, CT-guided CNB technique also revealed its effectiveness in cases where pleural effusion was present and we have also used it in cases of thin pleural thickening. To achieve adequate diagnostic samples in patients with thin (0.5-1 cm) pleural thickening, we used a tangential approach, which proved its effectiveness in gathering biopsy tissues. Third, the accuracy for diagnosis of pleural lesion with CTguided CNB in this study (89.2%) is only slightly lower than the published sensitivities from thoracoscopy series (91-95%) (6, 7) . Accordingly, it is hypothesized that this technique might be used as an alternative in the absence of thoracoscopy or if the patient is unfit for thoracoscopy.
Generally, it is implicited that pneumothorax is the most common complication of lung needle biopsy (16, 17) . In our study, the pneumothorax rate (16%) and consequential chest tube insertion rate (2%) of CT-guided CNB for pleural lesion were within the range of those in prior publications (10, 12, 18) . Multivariate analysis showed an increased risk of pneumothorax with decrease in lesion size, as also reported by previous studies, and a correlation between reduced lesion sizes with a higher number of complications was noted. In the case of pneumothorax, this may be due to the number of pleural needle passes required to obtain correct needle direction, which as a result, increases the number of minor pleural injuries. On the other hand, the presence of pleural effusion significantly reduced the occurrence of pneumothorax. It is assumed that pleural effusion may seal off the needle tract and block air leakage into the pleural space, which, in turn can contribute to a decrease in the pneumothorax rate.
According to a study by Sconfienza et al. (18) , US guidance is comparable to CT guidance in terms of sample accuracy and allows for a significant reduction in procedure time and post-procedural pneumothorax. In addition, it does not require ionizing radiation. However, there is still no randomized study on comparison between diagnostic yields of ultrasound-guided with CT-guided pleural biopsy. However, reported figures suggest that the latter may have a marginally higher yield (12, (19) (20) (21) (22) (23) (24) (25) . Currently, all imagingguided thoracic biopsies at our institution are routinely performed under CT guidance. For abdominal biopsy, we favor the use of US guidance because it is faster, easier and less cumbersome. Therefore, the outcome of this study is There are certain limitations to this study. First, it is a retrospective analysis and preconceived notion may have existed. Second, the individual radiologist's preference for a needle path and angle (based on their level of expertise) was difficult to evaluate. Third, four of 88 lesions (5%) were regarded as undetermined. Fourth, our study did not include very small pleural lesions/pleural thickening (< 5 mm).
In conclusion, it is appropriate to state CT-guided core needle biopsy of pleural lesion as a safe procedure with high diagnostic yield and low risk of significant complications.
